TP53 and neoplasm: The data herein demonstrate that MTDIA and AG-270 have synergistic effects in reducing cell growth in vitro through the increase in the MTA:SAM metabolite ratio that inhibits PRMT5 activity and resulting in downstream effects on RNA splicing activity, p53 activation, cell growth arrest, and tumor growth inhibition in murine xenograft models.